Domainex is a UK-based drug discovery contract research organization (CRO) focused on small-molecule development. They offer integrated services across medicinal chemistry, computational chemistry, biology, and structural biology to support lead discovery and optimization. Domainex’s multidisciplinary approach enables biotech and pharmaceutical clients to accelerate the discovery of novel therapeutic candidates.